Corrigendum to “Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease” [Neurobiology of Disease, 2024 Jan:190:106376]
Volume 193, April 2024, 106444
Author links open overlay panelStefan Bartl a 1, Yuanyun Xie b c, Nalini Potluri b, Ratnesh Kesineni b, Katlin Hencak b, Louisa Dal Cengio c, Katja Balazs d, Abid Oueslati e, Michela Parth d, Nina Salhat d, Alberto Siddu e, Oskar Smrzka d 2, Francesca Cicchetti e, Günther Staffler d 3, Michael R. Hayden c, Amber L. Southwell bShow morePrevious article in issueNext article in issue
Recommended articles
1Former address: AFFiRiS AG, Vienna, Austria.
2Present address: Ablevia Biotech, Vienna, Austria.
3Present address: AC Immune, Lausanne, Switzerland.
© 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Recommended articlesArticle Metrics
留言 (0)